106 related articles for article (PubMed ID: 16243564)
61. Prospects and challenges for prophylactic and therapeutic HIV vaccines.
Klein M
Vaccine; 2003 Jan; 21(7-8):616-9. PubMed ID: 12531328
[TBL] [Abstract][Full Text] [Related]
62. AIDS. European vaccine effort faces Chinese puzzle.
Balter M
Science; 1999 Nov; 286(5442):1062-3. PubMed ID: 10610516
[No Abstract] [Full Text] [Related]
63. HIV vaccine--immune response. AG 1661, IR-8101, IR8101, REMUNE, RG 83894.
Drugs R D; 2002; 3(6):411-20. PubMed ID: 12516948
[No Abstract] [Full Text] [Related]
64. Is anti-p27nef a useful diagnostic and prognostic marker in HIV-1 infection?
Marty L; Laperche S; Bouchardeau F; Faucher V; Lefrere JJ; Couroucé AM
AIDS; 1990 Nov; 4(11):1170-1. PubMed ID: 2282200
[No Abstract] [Full Text] [Related]
65. M918: A Novel Cell Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef Proteins into Eukaryotic Cell Lines.
Rostami B; Irani S; Bolhassani A; Cohan RA
Curr HIV Res; 2018; 16(4):280-287. PubMed ID: 30520377
[TBL] [Abstract][Full Text] [Related]
66. On the HIV nef gene product. 3rd forum in virology.
Res Virol; 1992; 143(1):29-81. PubMed ID: 1348866
[No Abstract] [Full Text] [Related]
67. On the HIV nef gene product.
Hovanessian AG
Res Virol; 1992; 143(1):31-4. PubMed ID: 1565851
[No Abstract] [Full Text] [Related]
68. Advantageous features of plant-based systems for the development of HIV vaccines.
Horn ME; Pappu KM; Bailey MR; Clough RC; Barker M; Jilka JM; Howard JA; Streatfield SJ
J Drug Target; 2003; 11(8-10):539-45. PubMed ID: 15203923
[TBL] [Abstract][Full Text] [Related]
69. Volunteers recruited for Merck's HIV/AIDS vaccine.
AIDS Policy Law; 2004 Jul; 19(13):2. PubMed ID: 15300929
[No Abstract] [Full Text] [Related]
70. New technologies for making vaccines.
Ellis RW
Vaccine; 1999 Mar; 17(13-14):1596-604. PubMed ID: 10194811
[TBL] [Abstract][Full Text] [Related]
71. B-cell epitopes of the Nef protein.
Spohn R; Gombert FO; Jung G
Res Virol; 1992; 143(1):70-2. PubMed ID: 1373514
[No Abstract] [Full Text] [Related]
72. Fighting HIV with HIV.
Secasan IS; Pop DI
Med Hypotheses; 1998 Jan; 50(1):39-42. PubMed ID: 9488180
[No Abstract] [Full Text] [Related]
73. Where now for AIDS vaccines?
Gottlieb S
BMJ; 1998 Jul; 317(7152):163. PubMed ID: 9705637
[No Abstract] [Full Text] [Related]
74. Towards new vaccines and modern vaccinology: introductory remarks.
Kurstak E
Vaccine; 1999 Mar; 17(13-14):1583-6. PubMed ID: 10194809
[No Abstract] [Full Text] [Related]
75. Editorial: An emerging immunogenomics and computational approach for peptide vaccinology: rational design of peptide vaccines.
Nandy A; Basak SC
Curr Comput Aided Drug Des; 2014; 10(4):283-4. PubMed ID: 25994637
[No Abstract] [Full Text] [Related]
76. BIOLOGICAL PRODUCTS. II. COMBINED VACCINES.
MATHIESON AJ
Br Med J; 1963 Sep; 2(5358):669-71. PubMed ID: 14044873
[No Abstract] [Full Text] [Related]
77. Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.
Rodríguez JW; Pagan NO; Ocasio MC; Ríos Z; Cubano LA; Boukli NM; Otero M; Hunter R; Nair MP; Rios-Olivares E
Am J Infect Dis; 2007; 3(4):. PubMed ID: 24327810
[TBL] [Abstract][Full Text] [Related]
78. IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.
Rodríguez AM; Pascutti MF; Maeto C; Falivene J; Holgado MP; Turk G; Gherardi MM
PLoS One; 2012; 7(5):e37801. PubMed ID: 22655069
[TBL] [Abstract][Full Text] [Related]
79. Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines.
Wang Z; Martinez J; Zhou W; La Rosa C; Srivastava T; Dasgupta A; Rawal R; Li Z; Britt WJ; Diamond D
Vaccine; 2010 Feb; 28(6):1547-57. PubMed ID: 19969118
[TBL] [Abstract][Full Text] [Related]
80. Vaccines based on Nef and on Nef/DeltaV2 Env.
Erfle V; Goebel FD; Guzman CA; Le Grand R
Microbes Infect; 2005 Nov; 7(14):1400-4. PubMed ID: 16243564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
